Through our venture philanthropy model, we provide early stage funding to companies to develop breakthrough drugs for adults and children with cystic fibrosis.
Site Search
Showing 1 - 10 of 105 results
Learn about our focus for 2020-2024 as we advance our path to a cure, meet emerging challenges in care, and explore new ways to partner with and support the CF community.
10 min read
Engaging with biotechnology and pharmaceutical companies is essential to reaching our goal of a cure for all people with cystic fibrosis. These principles and standards for Industry interactions safeguard our independence, objectivity, and ability to make decisions that are in the best interest of people with CF.
13 min read
Historic Time in Treatment of Rare Disease as Promising Drugs Reach Phase 3 Trials
Press Release
|
|
3 min read
Legislation to Help Speed Research for Cystic Fibrosis and Other Rare Diseases
Press Release
|
|
4 min read
Press Release
|
|
2 min read
Cystic Fibrosis Foundation Drug Development Model Spawns More Than 30 Promising Therapies
Press Release
|
|
3 min read
Press Release
|
|
6 min read
Press Release
|
|
3 min read
Galapagos and Cystic Fibrosis Foundation Therapeutics Sign €1.3 million* Agreement
Press Release
|
|
4 min read